Amedisys (AMED) | Stock Overview & Key Data
Amedisys Performance Comparison
Stock Range
Today's Range
Low: $100.99
High: $100.99
on August 15, 2025
52 Week Range
Low: $82.15
High: $101.02
on December 20, 2024
on August 14, 2025
All-Time High: $325.12 on January 25, 2021
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$3.3B
EPS
2.57
P/E Ratio (TTM)
39.30
Forward P/E
19.76
P/B Ratio
2.69
PEG Ratio
-2.78
Div. Yield
N/A
ROE
6.67%
Beta
0.901
Debt to Equity
35.34
Financial Highlights
Profitability
Gross Margin
43.96%
Operating Margin
11.70%
Profit Margin
3.56%
Returns and Earnings
Return on Assets (TTM)
6.52%
Return on Equity (TTM)
6.67%
EBITDA
$365.0M
Net Income (TTM)
$85.6M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$73.30
Quarterly Revenue Growth (YoY)
5.20%
Quarterly Earnings Growth (YoY)
-13.10%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Amedisys AMED | 3.32B Mid-cap | 0.05% | 3.57% | 7.76% | 9.12% | 11.10% | 2.68% | -14.45% | -58.43% |
| HCA Healthcare HCA | 100.93B Large-cap | 3.00% | 3.70% | 14.40% | 31.53% | 45.61% | 9.89% | 115.19% | 220.86% |
| Encompass Health EHC | 12.63B Large-cap | -1.79% | -1.86% | 3.54% | 27.83% | 34.59% | 28.81% | 162.80% | 128.33% |
| Ensign Group ENSG | 10.12B Large-cap | 3.31% | 1.78% | 20.09% | 42.20% | 33.38% | 20.36% | 113.78% | 205.45% |
| DaVita DVA | 9.39B Mid-cap | -1.88% | -4.74% | -10.27% | -12.60% | -14.47% | -20.34% | 43.35% | 41.15% |
| Chemed CHE | 6.78B Mid-cap | -3.70% | -6.12% | -5.50% | -24.29% | -17.54% | -26.19% | 0.67% | -12.54% |
Ownership & Short Interest
Insider Ownership
1.95%
Institutional Ownership
96.37%
Shares Short
3M
Short Ratio
6.84
Short % of Shares Outstanding
9.90%
Average 10-Day Volume
1M
Average 90-Day Volume
619K
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is AMED's 52-week high and low?
- In the last 52 weeks, Amedisys reached a high of $101.02 (on August 14, 2025) and a low of $82.15 (on December 20, 2024).
- What is the market cap and P/E ratio for AMED?
- Curious about Amedisys's size and valuation? Its market capitalization stands at 3.32B. When it comes to valuation, the P/E ratio (trailing twelve months) is 39.30, and the forward P/E (looking ahead) is 19.76.
- Does AMED pay dividends? If so, what's the yield?
- As for dividends, Amedisys isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Amedisys's main competitors or similar companies to consider before investing?
When looking at Amedisys, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return HCA Healthcare
HCA100.93B Healthcare Medical Care Facilities 9.89% 115.19% Encompass Health
EHC12.63B Healthcare Medical Care Facilities 28.81% 162.80% Ensign Group
ENSG10.12B Healthcare Medical Care Facilities 20.36% 113.78% DaVita
DVA9.39B Healthcare Medical Care Facilities -20.34% 43.35% Chemed
CHE6.78B Healthcare Medical Care Facilities -26.19% 0.67% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Amedisys Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Amedisys's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 6.67%, the Debt to Equity ratio from the most recent quarter is 35.34, and its Gross Profit Margin stands at 43.96%.
- What is the recent revenue and earnings growth for AMED?
- Looking at Amedisys's growth, its revenue over the trailing twelve months (TTM) was $2B. Compared to the same quarter last year (YoY), quarterly revenue grew by 5.20%, and quarterly earnings saw a YoY growth of -13.10%.
- How much of AMED stock is held by insiders and institutions?
- Wondering who owns Amedisys stock? Company insiders (like executives and directors) hold about 1.95% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 96.37%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.